BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

BioDlink's bevacizumab receives marketing approval in Colombia, Pakistan

This move is a significant step in the company’s global expansion strategy, focusing on enhancing the availability of essential cancer therapies. Bevacizumab is a targeted therapy designed to The post BioDlink’s bevacizumab receives marketing approval in Colombia, Pakistan appeared first on Pharmaceutical Business review.

BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

– BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria, marking key regulatory milestones in high-need emerging markets. – GMP certification in Brazil, Colombia, and Argentina spans the top three most populous countries in South America, collectively representing 71.4% of the continent’s population. – Backed by a globally recognized quality […]